title: Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies.
abstract: Findings among a cohort of 26 patients who had hematologic malignancies and hepatitis E virus (HEV) infection support that HEV can induce chronic hepatitis. However, a 3-month course of ribavirin can induce a rapid viral clearance, reducing the risk for chronic hepatitis and enabling continuation of cytotoxic treatments for underlying malignancies.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Tavitian
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Peron
authors.forename: Françoise
authors.initials: F
authors.lastname: Huguet
authors.forename: Nassim
authors.initials: N
authors.lastname: Kamar
authors.forename: Florence
authors.initials: F
authors.lastname: Abravanel
authors.forename: Odile
authors.initials: O
authors.lastname: Beyne-Rauzy
authors.forename: Lucie
authors.initials: L
authors.lastname: Oberic
authors.forename: Stanislas
authors.initials: S
authors.lastname: Faguer
authors.forename: Laurent
authors.initials: L
authors.lastname: Alric
authors.forename: Murielle
authors.initials: M
authors.lastname: Roussel
authors.forename: Clément
authors.initials: C
authors.lastname: Gaudin
authors.forename: Loïc
authors.initials: L
authors.lastname: Ysebaert
authors.forename: Anne
authors.initials: A
authors.lastname: Huynh
authors.forename: Christian
authors.initials: C
authors.lastname: Recher
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D016751:Hepatitis E / Q000188:drug therapy* / Q000517:prevention & control / Q000821:virology; D016752:Hepatitis E virus / Q000235:genetics*; D006521:Hepatitis, Chronic / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin
keywords: Hepatitis E; chronic hepatitis; cirrhosis; hematology; malignancy; ribavirin; viruses